T., Yang, Y
doi: 10.1038/s41422-020-0379-5 258 SiesH
Acetylcysteine solution, USP is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) Pulmonary complications of cystic fibrosis Tracheostomy care Pulmonary complications associated with surgery Use during anesthesia Post-traumatic chest conditions Atelectasis due to mucous obstruction Diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) Acetylcysteine solution is contraindicated in those patients who are sensitive to it
ROS can influence the modification of specific protein motifs, alter metabolic pathways, and induce secondary effects through cellular processes such as apoptosis, inflammatory responses, and NETosis (75)
[DOI] [PubMed] [Google Scholar] 96.Valipour A., Hamnabard N., Ahn Y.H
Do not consume a daily amount equal to or greater than 800 mg of EGCG
